Free Trial
→ The 401k Email 70 Million Investors Might Delete (From Brownstone Research) (Ad)tc pixel Free IEX Stock Alerts

IDEX (IEX) Financials

IDEX logo
$233.73 -5.60 (-2.34%)
Closing price 10/30/2026 03:59 PM Eastern
Extended Trading
$233.88 +0.15 (+0.06%)
As of 10/30/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for IDEX

Annual Income Statements for IDEX

This table shows IDEX's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 283 271 337 411 426 378 449 587 596 505 483
Consolidated Net Income / (Loss)		 283 271 337 411 426 378 449 587 596 505 483
Net Income / (Loss) Continuing Operations		 283 271 337 411 426 378 449 587 596 505 483
Total Pre-Tax Income 		392 369 455 529 533 470 580 749 760 639 633
Total Operating Income		 419 435 493 569 579 521 637 751 733 677 699
Total Gross Profit		 904 931 1,027 1,118 1,125 1,027 1,225 1,427 1,447 1,445 1,539
Total Revenue		 2,021 2,113 2,287 2,484 2,495 2,352 2,765 3,182 3,274 3,269 3,458
Operating Revenue		 2,021 2,113 2,287 2,484 2,495 2,352 2,765 3,182 3,274 3,269 3,458
Total Cost of Revenue		 1,116 1,182 1,261 1,366 1,370 1,324 1,540 1,755 1,827 1,824 1,919
Operating Cost of Revenue		 1,116 1,182 1,261 1,366 1,370 1,324 1,540 1,755 1,827 1,824 1,919
Total Operating Expenses		 485 496 533 549 546 507 588 676 714 768 840
Selling, General & Admin Expense		 474 492 525 537 525 495 578 653 704 759 819
Restructuring Charge		 11 3.67 8.46 12 21 12 9.30 23 11 9.30 21
Total Other Income / (Expense), net		 -27 -66 -38 -40 -46 -50 -57 -2.00 28 -38 -67
Interest & Investment Income		 - - - - - - - -41 -52 -45 -64
Other Income / (Expense), net		 15 -21 6.88 3.99 -1.80 -5.60 -16 39 80 6.60 -2.30
Income Tax Expense		 110 97 118 118 107 93 131 163 165 135 150
Net Income / (Loss) Attributable to Noncontrolling Interest		 - - - - 0.00 0.00 -0.10 -0.20 -0.50 -0.40 -0.70
Basic Earnings per Share		 $3.65 $3.57 $4.41 $5.36 $5.62 $4.98 $5.91 $7.74 $7.87 $6.66 $6.41
Weighted Average Basic Shares Outstanding		 77.13M 75.80M 76.23M 76.41M 75.60M 75.70M 76M 75.70M 75.60M 75.70M 75.30M
Diluted Earnings per Share		 $3.62 $3.53 $4.36 $5.29 $5.56 $4.94 $5.88 $7.71 $7.85 $6.64 $6.41
Weighted Average Diluted Shares Outstanding		 77.97M 76.76M 77.33M 77.56M 76.50M 76.40M 76.40M 76M 75.90M 75.90M 75.30M
Weighted Average Basic & Diluted Shares Outstanding		 77.50M 75.90M 76.50M 76.60M 76.21M 75.89M 76.12M 75.52M 75.64M 75.78M 74.35M
Cash Dividends to Common per Share		 $1.28 $1.36 $1.48 $1.72 $2.00 $2.00 $2.16 $2.40 $2.56 $2.76 $2.84

Quarterly Income Statements for IDEX

This table shows IDEX's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 121 141 119 123 96 132 128 128 120 143 144
Consolidated Net Income / (Loss)		 121 141 119 123 95 131 128 128 120 143 144
Net Income / (Loss) Continuing Operations		 121 141 119 123 95 131 128 128 120 143 144
Total Pre-Tax Income 		155 179 154 151 125 170 171 168 157 186 193
Total Operating Income		 161 183 168 165 142 188 186 184 172 200 208
Total Gross Profit		 357 367 354 367 369 392 391 387 398 427 430
Total Revenue		 801 807 798 863 814 865 879 899 887 921 952
Operating Revenue		 801 807 798 863 814 865 879 899 887 921 952
Total Cost of Revenue		 443 440 444 496 445 473 488 512 489 494 522
Operating Cost of Revenue		 443 440 444 496 445 473 488 512 489 494 522
Total Operating Expenses		 196 184 186 202 227 204 205 204 226 227 222
Selling, General & Admin Expense		 195 183 183 198 209 204 205 201 218 224 218
Restructuring Charge		 1.10 1.30 3.00 3.90 18 0.70 0.10 2.40 7.40 2.80 3.40
Total Other Income / (Expense), net		 -6.70 -3.50 -14 -14 -18 -18 -15 -16 -15 -14 -15
Interest & Investment Income		 -9.40 -8.10 -10 - -16 -16 -17 -16 -16 -15 -15
Other Income / (Expense), net		 2.70 4.60 -3.30 2.60 -1.40 -2.40 1.20 0.30 0.60 1.30 0.10
Income Tax Expense		 33 38 36 28 29 39 43 39 37 43 49
Net Income / (Loss) Attributable to Noncontrolling Interest		 -0.10 -0.10 -0.20 - -0.10 -0.50 -0.10 - -0.10 0.00 -0.10
Basic Earnings per Share		 $1.60 $1.86 $1.57 $1.63 $1.26 $1.74 $1.70 $1.71 $1.61 $1.94 $1.95
Weighted Average Basic Shares Outstanding		 75.70M 75.70M 75.70M 75.70M 75.70M 75.50M 75.10M 75.30M 74.30M 74M 73.70M
Diluted Earnings per Share		 $1.60 $1.86 $1.57 $1.61 $1.26 $1.74 $1.70 $1.71 $1.61 $1.93 $1.95
Weighted Average Diluted Shares Outstanding		 75.90M 75.90M 75.90M 75.90M 75.80M 75.50M 75.20M 75.30M 74.40M 74.20M 74M
Weighted Average Basic & Diluted Shares Outstanding		 75.70M 75.70M 75.72M 75.78M 75.54M 75.29M 74.85M 74.35M 74.02M 73.72M 73.45M

Annual Cash Flow Statements for IDEX

This table details how cash moves in and out of IDEX's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -181 -92 140 90 166 393 -171 -425 104 105 -53
Net Cash From Operating Activities		 360 400 433 479 528 569 565 557 717 668 680
Net Cash From Continuing Operating Activities		 360 400 433 479 528 569 565 557 717 668 680
Net Income / (Loss) Continuing Operations		 283 271 337 411 426 378 449 587 596 505 483
Consolidated Net Income / (Loss)		 283 271 337 411 426 378 449 587 596 505 483
Depreciation Expense		 36 38 38 39 40 42 47 51 57 69 76
Amortization Expense		 44 50 47 40 39 44 56 69 95 107 131
Non-Cash Adjustments To Reconcile Net Income		 4.42 53 22 32 39 24 33 4.20 -54 22 28
Changes in Operating Assets and Liabilities, net		 -6.64 -13 -12 -42 -14 82 -20 -153 23 -34 -37
Net Cash From Investing Activities		 -210 -509 -55 -81 -137 -173 -698 -917 -284 -1,007 -138
Net Cash From Continuing Investing Activities		 -210 -509 -55 -81 -137 -173 -698 -917 -284 -1,007 -138
Purchase of Property, Plant & Equipment		 -44 -38 -44 -56 -51 -52 -73 -68 -90 -65 -64
Acquisitions		 -195 -510 -38 -24 -87 -123 -577 -946 -312 -985 -76
Purchase of Investments		 - - - - - 0.00 -45 0.00 -29 0.00 0.00
Divestitures		 28 39 22 0.00 - 0.00 0.00 49 119 45 0.00
Sale and/or Maturity of Investments		 - - - - - 0.00 0.00 40 25 4.50 0.00
Other Investing Activities, net		 0.62 -0.02 5.48 -1.50 1.10 2.10 -2.80 7.30 3.50 -6.50 2.20
Net Cash From Financing Activities		 -296 47 -277 -290 -228 -43 -9.50 -38 -345 466 -633
Net Cash From Continuing Financing Activities		 -296 47 -277 -290 -228 -43 -9.50 -38 -345 466 -633
Repayment of Debt		 -424 -520 -201 -11 -52 -455 -355 -137 -251 -122 -424
Repurchase of Common Equity		 -211 -57 -29 -174 -55 -110 0.00 -148 -24 0.00 -248
Payment of Dividends		 -96 -103 -111 -127 -147 -152 -161 -177 -191 -205 -213
Issuance of Debt		 414 702 33 0.00 - 649 499 410 100 776 252
Other Financing Activities, net		 21 25 30 23 26 26 -6.70 - 22 17 -0.50
Effect of Exchange Rate Changes		 -35 -29 39 -17 - - - -28 16 -23 37
Cash Interest Paid		 34 37 37 36 37 35 36 37 51 47 72
Cash Income Taxes Paid		 113 109 105 91 109 87 118 176 200 171 135

Quarterly Cash Flow Statements for IDEX

This table details how cash moves in and out of IDEX's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents		 82 84 -49 -12 -27 -42 30 -14 5.90 36 -21
Net Cash From Operating Activities		 157 134 205 173 106 162 204 210 104 200 240
Net Cash From Continuing Operating Activities		 157 134 205 173 106 162 204 210 104 200 240
Net Income / (Loss) Continuing Operations		 121 141 119 123 95 131 128 128 120 143 144
Consolidated Net Income / (Loss)		 121 141 119 123 95 131 128 128 120 143 144
Depreciation Expense		 16 16 17 19 18 19 19 19 20 20 21
Amortization Expense		 25 24 27 32 32 32 33 34 34 33 33
Non-Cash Adjustments To Reconcile Net Income		 13 -0.20 4.60 5.00 14 5.80 5.00 3.60 21 6.10 5.70
Changes in Operating Assets and Liabilities, net		 -18 -48 38 -6.30 -53 -26 19 24 -91 -2.90 36
Net Cash From Investing Activities		 -20 32 -1,004 -15 -10 -15 -96 -18 -20 -22 -25
Net Cash From Continuing Investing Activities		 -20 32 -1,004 -15 -10 -15 -96 -18 -20 -22 -25
Purchase of Property, Plant & Equipment		 -20 -16 -14 -16 -14 -15 -15 -20 -18 -23 -25
Other Investing Activities, net		 0.00 0.50 -7.80 0.80 0.10 0.30 - 1.80 -2.70 0.70 0.20
Net Cash From Financing Activities		 -41 -77 725 -141 -133 -216 -76 -208 -69 -139 -233
Net Cash From Continuing Financing Activities		 -41 -77 725 -141 -133 -216 -76 -208 -69 -139 -233
Repayment of Debt		 -0.20 -25 -1.40 -95 -30 -163 -93 -137 -46 -118 -165
Repurchase of Common Equity		 0.00 - - - -50 -50 -75 -73 -76 -77 -75
Payment of Dividends		 -49 -52 -52 -52 -52 -54 -54 -53 -53 -54 -54
Issuance of Debt		 - - 776 - 0.00 - 147 55 100 105 55
Other Financing Activities, net		 7.70 - - - -0.50 0.30 -1.00 0.70 5.80 4.80 5.10
Effect of Exchange Rate Changes		 -14 -3.70 24 - - 27 -2.60 2.00 -8.60 -2.10 -2.20
Cash Interest Paid		 2.40 21 2.50 22 16 21 15 20 15 19 15
Cash Income Taxes Paid		 18 66 36 51 20 64 20 31 20 62 47

Annual Balance Sheets for IDEX

This table presents IDEX's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 2,805 3,155 3,400 3,474 3,814 4,414 4,917 5,512 5,865 6,745 6,927
Total Current Assets		 863 823 1,004 1,093 1,261 1,657 1,678 1,399 1,446 1,593 1,643
Cash & Equivalents		 328 236 376 466 633 1,026 855 430 534 621 580
Accounts Receivable		 260 273 294 312 298 293 356 443 428 466 522
Inventories, net		 239 253 260 280 293 290 370 471 421 430 479
Other Current Assets		 36 61 74 34 37 48 96 55 63 76 62
Plant, Property, & Equipment, net		 241 248 258 281 280 298 327 382 430 460 468
Total Noncurrent Assets		 1,702 2,084 2,137 2,100 2,272 2,459 2,912 3,731 3,989 4,692 4,816
Goodwill		 1,397 1,633 1,704 1,698 1,780 1,896 2,168 2,638 2,838 3,252 3,415
Intangible Assets		 288 436 415 383 388 416 597 948 1,012 1,285 1,247
Other Noncurrent Operating Assets		 17 16 18 19 104 148 147 145 139 156 154
Total Liabilities & Shareholders' Equity		 2,805 3,155 3,400 3,474 3,814 4,414 4,917 5,512 5,865 6,745 6,927
Total Liabilities		 1,362 1,611 1,513 1,479 1,551 1,874 2,114 2,472 2,324 2,951 2,901
Total Current Liabilities		 310 309 361 365 358 399 480 544 500 630 575
Short-Term Debt		 - - - 0.48 0.39 0.10 - 0.00 0.60 101 0.70
Accounts Payable		 129 129 147 143 138 152 179 209 180 198 225
Accrued Expenses		 154 153 185 188 180 209 260 289 272 279 297
Dividends Payable		 26 26 29 33 39 38 41 46 49 53 53
Total Noncurrent Liabilities		 1,053 1,302 1,152 1,115 1,193 1,475 1,634 1,929 1,824 2,322 2,325
Long-Term Debt		 840 1,014 859 848 849 1,044 1,190 1,469 1,325 1,860 1,820
Noncurrent Deferred & Payable Income Tax Liabilities		 110 166 138 128 147 164 196 264 292 267 303
Other Noncurrent Operating Liabilities		 102 121 156 138 197 267 247 196 207 195 202
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,443 1,544 1,887 1,995 2,263 2,540 2,803 3,040 3,541 3,794 4,026
Total Preferred & Common Equity		 1,443 1,544 1,887 1,995 2,263 2,540 2,803 3,039 3,541 3,795 4,028
Preferred Stock		 - - - 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00
Total Common Equity		 1,443 1,544 1,887 1,995 2,263 2,540 2,803 3,039 3,541 3,795 4,028
Common Stock		 681 698 718 739 761 776 797 818 840 866 893
Retained Earnings		 1,667 1,835 2,058 2,342 2,615 2,842 3,127 3,532 3,934 4,230 4,500
Treasury Stock		 -757 -787 -800 -957 -986 -1,064 -1,050 -1,184 -1,187 -1,170 -1,423
Accumulated Other Comprehensive Income / (Loss)		 -146 -202 -90 -129 -127 -14 -70 -126 -46 -131 58
Noncontrolling Interest		 - - - - 0.00 0.10 0.00 0.30 -0.20 -0.60 -1.30

Quarterly Balance Sheets for IDEX

This table presents IDEX's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets		 5,865 5,889 5,903 6,968 6,745 6,795 6,876 6,970 6,919 6,930 6,879
Total Current Assets		 1,446 1,555 1,630 1,678 1,593 1,627 1,617 1,655 1,717 1,773 1,767
Cash & Equivalents		 534 616 701 633 621 594 568 594 586 621 602
Accounts Receivable		 428 438 426 475 466 483 476 500 553 548 549
Inventories, net		 421 426 428 488 430 466 488 495 501 520 529
Other Current Assets		 63 74 75 81 76 84 84 66 77 84 87
Plant, Property, & Equipment, net		 430 428 419 469 460 460 465 469 462 464 467
Total Noncurrent Assets		 3,989 3,907 3,855 4,821 4,692 4,709 4,795 4,846 4,740 4,693 4,645
Goodwill		 2,838 2,803 2,787 3,316 3,252 3,287 3,369 3,409 3,390 3,383 3,372
Intangible Assets		 1,012 969 931 1,349 1,285 1,268 1,269 1,282 1,200 1,165 1,129
Other Noncurrent Operating Assets		 139 135 137 156 156 154 157 156 149 146 145
Total Liabilities & Shareholders' Equity		 5,865 5,889 5,903 6,968 6,745 6,795 6,876 6,970 6,919 6,930 6,879
Total Liabilities		 2,324 2,271 2,250 3,149 2,951 2,889 2,866 2,960 2,870 2,923 2,864
Total Current Liabilities		 500 461 477 565 630 584 530 564 506 582 636
Short-Term Debt		 0.60 0.70 0.60 0.60 101 101 0.80 0.70 0.50 0.40 0.40
Accounts Payable		 180 186 172 210 198 208 204 208 225 234 238
Accrued Expenses		 272 274 252 301 279 275 271 302 281 294 343
Dividends Payable		 49 0.00 52 52 53 0.00 54 53 0.10 54 54
Total Noncurrent Liabilities		 1,824 1,811 1,773 2,585 2,322 2,306 2,336 2,396 2,364 2,342 2,228
Long-Term Debt		 1,325 1,323 1,297 2,075 1,860 1,839 1,847 1,902 1,872 1,859 1,751
Noncurrent Deferred & Payable Income Tax Liabilities		 292 286 281 301 267 273 283 288 300 298 296
Other Noncurrent Operating Liabilities		 207 202 194 208 195 193 206 206 193 186 181
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 3,541 3,618 3,653 3,818 3,794 3,906 4,010 4,010 4,048 4,007 4,015
Total Preferred & Common Equity		 3,541 3,619 3,654 3,819 3,795 3,907 4,012 4,011 4,050 4,008 4,017
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 3,541 3,619 3,654 3,819 3,795 3,907 4,012 4,011 4,050 4,008 4,017
Common Stock		 840 852 857 861 866 879 885 889 869 876 883
Retained Earnings		 3,934 4,056 4,093 4,159 4,230 4,326 4,350 4,425 4,620 4,655 4,746
Treasury Stock		 -1,187 -1,179 -1,179 -1,177 -1,170 -1,221 -1,271 -1,348 -1,454 -1,525 -1,597
Accumulated Other Comprehensive Income / (Loss)		 -46 -110 -116 -25 -131 -77 48 45 14 1.60 -15
Noncontrolling Interest		 -0.20 -0.30 -0.40 -0.60 -0.60 -0.70 -1.20 -1.30 -1.40 -1.40 -1.50

Annual Metrics And Ratios for IDEX

This table displays calculated financial ratios and metrics derived from IDEX's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -5.92% 4.57% 8.25% 8.58% 0.44% -5.73% 17.57% 15.09% 2.89% -0.16% 5.77%
EBITDA Growth		 0.15% -2.22% 16.60% 11.31% 0.54% -8.42% 20.57% 25.70% 5.97% -10.86% 5.13%
EBIT Growth		 -0.08% -4.57% 20.77% 14.58% 0.72% -10.76% 20.52% 27.27% 2.77% -15.79% 1.93%
NOPAT Growth		 -1.64% 5.91% 14.26% 20.89% 4.66% -9.52% 18.01% 19.17% -2.46% -6.85% -0.21%
Net Income Growth		 1.22% -4.14% 24.40% 21.74% 3.64% -11.21% 18.93% 30.58% 1.52% -15.28% -4.38%
EPS Growth		 4.93% -2.49% 23.51% 21.33% 5.10% -11.15% 19.03% 31.12% 1.82% -15.41% -3.46%
Operating Cash Flow Growth		 -2.08% 10.99% 8.21% 10.77% 10.17% 7.80% -0.70% -1.40% 28.58% -6.78% 1.84%
Free Cash Flow Firm Growth		 -52.21% -126.71% 762.62% 35.86% -17.60% -4.02% -126.12% -301.05% 188.87% -185.45% 247.71%
Invested Capital Growth		 6.63% 18.54% 2.09% 0.50% 4.49% 3.11% 22.43% 29.70% 6.24% 18.37% 2.58%
Revenue Q/Q Growth		 -1.18% 1.47% 2.49% 1.15% -0.32% 0.37% 3.75% 3.11% -0.66% 2.32% 1.06%
EBITDA Q/Q Growth		 0.88% -2.33% 8.90% 0.49% -0.83% 1.61% 4.15% 1.98% -1.80% 3.27% 2.13%
EBIT Q/Q Growth		 0.70% -3.31% 11.06% 0.93% -1.16% 1.50% 3.70% 1.65% -2.85% 2.41% 2.35%
NOPAT Q/Q Growth		 -0.79% 5.92% 3.38% 2.51% 0.05% 0.39% 3.63% 2.33% -2.49% 1.99% 1.08%
Net Income Q/Q Growth		 2.22% -3.70% 12.10% 1.08% -0.31% 1.14% 4.08% 1.96% -3.52% 3.04% 1.07%
EPS Q/Q Growth		 2.55% -3.55% 12.08% 1.15% 0.00% 0.82% 4.26% 2.12% -3.33% 2.63% 1.58%
Operating Cash Flow Q/Q Growth		 -0.78% 4.45% 4.99% 3.77% -0.45% 1.82% 0.30% 0.76% 4.93% -4.08% 5.73%
Free Cash Flow Firm Q/Q Growth		 -21.82% 65.94% -17.81% 9.96% -6.42% -2.89% -20.23% -196.86% 227.73% 54.53% -14.86%
Invested Capital Q/Q Growth		 -0.90% -3.79% -0.50% -1.64% -0.62% -0.15% 0.90% 22.79% 4.45% -2.39% -0.96%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 44.75% 44.05% 44.89% 45.01% 45.10% 43.69% 44.29% 44.84% 44.20% 44.21% 44.51%
EBITDA Margin		 25.42% 23.77% 25.61% 26.25% 26.28% 25.53% 26.18% 28.59% 29.45% 26.29% 26.13%
Operating Margin		 20.73% 20.57% 21.57% 22.91% 23.21% 22.14% 23.04% 23.61% 22.37% 20.72% 20.23%
EBIT Margin		 21.48% 19.60% 21.87% 23.07% 23.14% 21.90% 22.45% 24.83% 24.80% 20.92% 20.16%
Profit (Net Income) Margin		 14.00% 12.83% 14.74% 16.53% 17.06% 16.07% 16.25% 18.44% 18.19% 15.44% 13.96%
Tax Burden Percent		 72.08% 73.57% 74.08% 77.62% 79.85% 80.33% 77.49% 78.29% 78.34% 78.93% 76.27%
Interest Burden Percent		 90.41% 88.99% 91.03% 92.30% 92.33% 91.30% 93.40% 94.85% 93.63% 93.49% 90.76%
Effective Tax Rate		 27.92% 26.43% 25.92% 22.38% 20.15% 19.67% 22.51% 21.71% 21.66% 21.07% 23.73%
Return on Invested Capital (ROIC)		 15.72% 14.77% 15.39% 18.37% 18.76% 16.35% 17.09% 16.11% 13.49% 11.17% 10.15%
ROIC Less NNEP Spread (ROIC-NNEP)		 11.52% 7.52% 11.12% 11.65% 7.79% -9.59% -3.38% 15.90% 15.76% 8.49% 6.37%
Return on Net Nonoperating Assets (RNNOA)		 3.58% 3.39% 4.27% 2.79% 1.23% -0.62% -0.27% 3.97% 4.61% 2.58% 2.19%
Return on Equity (ROE)		 19.31% 18.15% 19.66% 21.16% 19.99% 15.73% 16.82% 20.08% 18.10% 13.76% 12.34%
Cash Return on Invested Capital (CROIC)		 9.31% -2.20% 13.33% 17.88% 14.37% 13.29% -3.07% -9.75% 7.44% -5.65% 7.60%
Operating Return on Assets (OROA)		 15.20% 13.90% 15.26% 16.67% 15.84% 12.52% 13.31% 15.15% 14.27% 10.84% 10.20%
Return on Assets (ROA)		 9.91% 9.10% 10.29% 11.95% 11.68% 9.18% 9.63% 11.25% 10.47% 8.00% 7.06%
Return on Common Equity (ROCE)		 19.31% 18.15% 19.66% 21.16% 19.99% 15.73% 16.82% 20.08% 18.10% 13.76% 12.34%
Return on Equity Simple (ROE_SIMPLE)		 19.59% 17.56% 17.88% 20.58% 18.80% 14.87% 16.03% 19.30% 16.82% 13.30% 0.00%
Net Operating Profit after Tax (NOPAT)		 302 320 365 442 462 418 494 588 574 535 533
NOPAT Margin		 14.94% 15.13% 15.98% 17.79% 18.53% 17.79% 17.85% 18.49% 17.53% 16.35% 15.43%
Net Nonoperating Expense Percent (NNEP)		 4.21% 7.24% 4.27% 6.72% 10.97% 25.94% 20.47% 0.21% -2.26% 2.68% 3.79%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 13.05% 11.79% 9.29% 9.12%
Cost of Revenue to Revenue		 55.25% 55.95% 55.11% 54.99% 54.90% 56.31% 55.71% 55.16% 55.81% 55.79% 55.49%
SG&A Expenses to Revenue		 23.47% 23.30% 22.95% 21.61% 21.05% 21.05% 20.91% 20.51% 21.49% 23.21% 23.68%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 24.02% 23.48% 23.32% 22.10% 21.89% 21.55% 21.25% 21.23% 21.82% 23.49% 24.28%
Earnings before Interest and Taxes (EBIT)		 434 414 500 573 577 515 621 790 812 684 697
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 514 502 586 652 656 600 724 910 964 859 904
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.64 4.05 4.93 4.54 5.47 5.69 6.20 5.51 4.56 4.16 3.29
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 129.71 63.08 456.23 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 2.60 2.96 4.07 3.64 4.96 6.14 6.29 5.26 4.94 4.83 3.84
Price to Earnings (P/E)		 18.57 23.07 27.60 22.05 29.10 38.24 38.68 28.54 27.11 31.28 27.46
Dividend Yield		 1.81% 1.63% 1.19% 1.41% 1.19% 1.05% 0.93% 1.05% 1.18% 1.30% 1.59%
Earnings Yield		 5.38% 4.33% 3.62% 4.54% 3.44% 2.62% 2.59% 3.50% 3.69% 3.20% 3.64%
Enterprise Value to Invested Capital (EV/IC)		 2.91 2.99 4.08 3.91 5.00 5.57 5.57 4.31 3.87 3.30 2.73
Enterprise Value to Revenue (EV/Rev)		 2.85 3.33 4.28 3.80 5.05 6.15 6.41 5.59 5.18 5.24 4.20
Enterprise Value to EBITDA (EV/EBITDA)		 11.22 14.00 16.72 14.47 19.22 24.09 24.48 19.55 17.58 19.94 16.06
Enterprise Value to EBIT (EV/EBIT)		 13.28 16.98 19.58 16.46 21.83 28.08 28.54 22.52 20.87 25.06 20.82
Enterprise Value to NOPAT (EV/NOPAT)		 19.09 21.99 26.80 21.36 27.25 34.58 35.89 30.24 29.54 32.06 27.20
Enterprise Value to Operating Cash Flow (EV/OCF)		 16.00 17.59 22.63 19.68 23.85 25.41 31.34 31.91 23.65 25.65 21.33
Enterprise Value to Free Cash Flow (EV/FCFF)		 32.25 0.00 30.95 21.95 35.57 42.55 0.00 0.00 53.56 0.00 36.33
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.58 0.66 0.46 0.43 0.38 0.41 0.42 0.48 0.37 0.52 0.45
Long-Term Debt to Equity		 0.58 0.66 0.46 0.43 0.38 0.41 0.42 0.48 0.37 0.49 0.45
Financial Leverage		 0.31 0.45 0.38 0.24 0.16 0.07 0.08 0.25 0.29 0.30 0.34
Leverage Ratio		 1.95 2.00 1.91 1.77 1.71 1.71 1.75 1.79 1.73 1.72 1.75
Compound Leverage Factor		 1.76 1.78 1.74 1.63 1.58 1.56 1.63 1.69 1.62 1.61 1.59
Debt to Total Capital		 36.78% 39.65% 31.28% 29.85% 27.29% 29.14% 29.81% 32.58% 27.24% 34.07% 31.14%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.02% 0.01% 0.00% 0.00% 0.00% 0.01% 1.75% 0.01%
Long-Term Debt to Total Capital		 36.78% 39.65% 31.28% 29.83% 27.27% 29.13% 29.81% 32.58% 27.23% 32.32% 31.13%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.00% -0.01% -0.02%
Common Equity to Total Capital		 63.22% 60.35% 68.72% 70.15% 72.71% 70.86% 70.19% 67.42% 72.77% 65.95% 68.88%
Debt to EBITDA		 1.63 2.02 1.47 1.30 1.30 1.74 1.64 1.61 1.38 2.28 2.02
Net Debt to EBITDA		 1.00 1.55 0.82 0.59 0.33 0.03 0.46 1.14 0.82 1.56 1.37
Long-Term Debt to EBITDA		 1.63 2.02 1.47 1.30 1.30 1.74 1.64 1.61 1.37 2.16 2.01
Debt to NOPAT		 2.78 3.17 2.35 1.92 1.84 2.50 2.41 2.50 2.31 3.67 3.41
Net Debt to NOPAT		 1.69 2.43 1.32 0.87 0.47 0.04 0.68 1.77 1.38 2.51 2.33
Long-Term Debt to NOPAT		 2.78 3.17 2.35 1.92 1.84 2.50 2.41 2.50 2.31 3.48 3.41
Altman Z-Score		 4.61 4.44 5.92 6.13 7.19 6.79 7.09 6.20 6.32 5.08 4.67
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.00% -0.01% -0.02%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.79 2.66 2.78 3.00 3.52 4.15 3.50 2.57 2.89 2.53 2.86
Quick Ratio		 1.90 1.65 1.86 2.14 2.60 3.31 2.52 1.61 1.92 1.73 1.91
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 179 -48 316 430 354 340 -89 -356 316 -270 399
Operating Cash Flow to CapEx		 823.10% 1,045.75% 986.71% 860.18% 1,037.52% 1,103.29% 777.58% 819.71% 797.22% 1,026.27% 1,069.81%
Free Cash Flow to Firm to Interest Expense		 4.29 -1.05 7.05 9.74 7.99 7.59 -2.17 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 8.65 8.77 9.64 10.86 11.92 12.71 13.79 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 7.60 7.93 8.66 9.60 10.77 11.56 12.01 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.71 0.71 0.70 0.72 0.68 0.57 0.59 0.61 0.58 0.52 0.51
Accounts Receivable Turnover		 7.83 7.93 8.07 8.19 8.17 7.95 8.51 7.96 7.52 7.32 7.00
Inventory Turnover		 4.68 4.81 4.92 5.06 4.78 4.54 4.67 4.17 4.10 4.29 4.22
Fixed Asset Turnover		 8.78 8.65 9.04 9.21 8.88 8.13 8.84 8.97 8.06 7.34 7.45
Accounts Payable Turnover		 8.71 9.17 9.14 9.41 9.73 9.12 9.31 9.05 9.40 9.66 9.08
Days Sales Outstanding (DSO)		 46.61 46.02 45.24 44.56 44.65 45.89 42.87 45.84 48.53 49.90 52.13
Days Inventory Outstanding (DIO)		 77.94 75.94 74.21 72.12 76.41 80.40 78.23 87.49 89.07 85.12 86.47
Days Payable Outstanding (DPO)		 41.91 39.80 39.96 38.79 37.53 40.03 39.19 40.32 38.82 37.78 40.19
Cash Conversion Cycle (CCC)		 82.63 82.16 79.49 77.89 83.54 86.26 81.91 93.01 98.79 97.23 98.41
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1,982 2,350 2,399 2,410 2,519 2,597 3,179 4,124 4,381 5,186 5,320
Invested Capital Turnover		 1.05 0.98 0.96 1.03 1.01 0.92 0.96 0.87 0.77 0.68 0.66
Increase / (Decrease) in Invested Capital		 123 368 49 12 108 78 582 944 257 805 134
Enterprise Value (EV)		 5,765 7,033 9,793 9,434 12,598 14,464 17,717 17,789 16,949 17,137 14,510
Market Capitalization		 5,253 6,255 9,310 9,052 12,381 14,445 17,382 16,750 16,158 15,798 13,270
Book Value per Share		 $18.86 $20.25 $24.69 $26.00 $29.76 $33.55 $36.87 $40.30 $46.83 $50.11 $53.81
Tangible Book Value per Share		 ($3.15) ($6.88) ($3.04) ($1.13) $1.26 $3.02 $0.50 ($7.25) ($4.08) ($9.80) ($8.48)
Total Capital		 2,283 2,558 2,745 2,843 3,112 3,585 3,993 4,508 4,867 5,754 5,847
Total Debt		 840 1,014 859 849 849 1,045 1,190 1,469 1,326 1,960 1,821
Total Long-Term Debt		 840 1,014 859 848 849 1,044 1,190 1,469 1,325 1,860 1,820
Net Debt		 512 778 483 382 217 19 335 1,039 791 1,339 1,241
Capital Expenditures (CapEx)		 44 38 44 56 51 52 73 68 90 65 64
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 225 278 267 262 271 232 343 426 412 443 489
Debt-free Net Working Capital (DFNWC)		 553 514 643 728 904 1,258 1,198 856 947 1,064 1,069
Net Working Capital (NWC)		 553 514 643 728 904 1,258 1,198 856 946 963 1,068
Net Nonoperating Expense (NNE)		 19 49 28 31 37 40 44 1.57 -22 30 51
Net Nonoperating Obligations (NNO)		 539 806 512 416 255 57 376 1,084 840 1,392 1,294
Total Depreciation and Amortization (D&A)		 80 88 86 79 78 85 103 120 152 176 207
Debt-free, Cash-free Net Working Capital to Revenue		 11.14% 13.14% 11.68% 10.55% 10.88% 9.88% 12.39% 13.37% 12.59% 13.55% 14.13%
Debt-free Net Working Capital to Revenue		 27.37% 24.30% 28.11% 29.33% 36.24% 53.51% 43.33% 26.89% 28.91% 32.54% 30.90%
Net Working Capital to Revenue		 27.37% 24.30% 28.11% 29.31% 36.22% 53.50% 43.33% 26.89% 28.90% 29.46% 30.88%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $3.65 $3.57 $4.41 $5.36 $5.62 $4.98 $5.91 $7.74 $7.87 $6.66 $6.41
Adjusted Weighted Average Basic Shares Outstanding		 77.13M 75.80M 76.23M 76.41M 75.59M 75.74M 76M 75.70M 75.60M 75.70M 75.30M
Adjusted Diluted Earnings per Share		 $3.62 $3.53 $4.36 $5.29 $5.56 $4.94 $5.88 $7.71 $7.85 $6.64 $6.41
Adjusted Weighted Average Diluted Shares Outstanding		 77.97M 76.76M 77.33M 77.56M 76.45M 76.40M 76.40M 76M 75.90M 75.90M 75.30M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 75.93M 76.25M 76.54M 75.79M 76.21M 75.89M 76.12M 75.52M 75.64M 75.78M 74.35M
Normalized Net Operating Profit after Tax (NOPAT)		 310 323 372 451 479 428 501 606 582 542 549
Normalized NOPAT Margin		 15.34% 15.26% 16.25% 18.16% 19.20% 18.19% 18.11% 19.05% 17.79% 16.58% 15.88%
Pre Tax Income Margin		 19.42% 17.44% 19.90% 21.30% 21.36% 20.00% 20.97% 23.55% 23.22% 19.56% 18.30%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 10.42 9.08 11.14 12.98 13.03 11.50 15.14 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 7.25 7.01 8.14 10.01 10.44 9.34 12.04 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 9.37 8.24 10.17 11.72 11.88 10.35 13.37 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 6.20 6.17 7.16 8.75 9.29 8.19 10.27 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 34.01% 37.86% 32.96% 31.05% 34.59% 40.18% 35.86% 30.24% 32.02% 40.69% 44.06%
Augmented Payout Ratio		 108.55% 58.99% 41.58% 73.41% 47.45% 69.38% 35.86% 55.48% 36.08% 40.69% 95.42%

Quarterly Metrics And Ratios for IDEX

This table displays calculated financial ratios and metrics derived from IDEX's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding		 - - - - - - - - 74,347,824.00 74,015,052.00 73,719,896.00
DEI Adjusted Shares Outstanding		 - - - - - - - - 74,347,824.00 74,015,052.00 73,719,896.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - 1.61 1.94 1.95
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -5.31% -4.61% 0.61% 9.38% 1.72% 7.21% 10.09% 4.20% 8.92% 6.38% 8.31%
EBITDA Growth		 -10.73% -0.83% -33.57% 14.21% -6.94% 3.96% 14.62% 8.60% 19.00% 7.65% 9.37%
EBIT Growth		 -15.03% -2.35% -40.22% 10.61% -14.22% -0.96% 13.54% 9.53% 23.04% 8.46% 11.28%
NOPAT Growth		 -15.36% -7.28% -9.77% 8.64% -14.03% 0.72% 7.56% 4.29% 21.00% 6.24% 11.69%
Net Income Growth		 -13.23% 1.95% -43.11% 13.76% -21.35% -7.15% 7.40% 4.14% 25.68% 9.38% 12.76%
EPS Growth		 -13.04% 2.20% -42.91% 11.81% -21.25% -6.45% 8.28% 6.21% 27.78% 10.92% 14.71%
Operating Cash Flow Growth		 5.88% -5.38% -9.40% -14.13% -32.50% 21.03% -0.88% 21.38% -1.89% 23.69% 17.69%
Free Cash Flow Firm Growth		 98.60% 125.44% -42.80% -402.34% -8,466.17% -588.45% 108.14% 100.96% 105.95% 122.27% 283.61%
Invested Capital Growth		 3.25% -0.91% 26.67% 18.37% 21.41% 24.18% 1.10% 2.58% 1.58% -0.85% -2.86%
Revenue Q/Q Growth		 1.47% 0.84% -1.12% 8.11% -5.63% 6.28% 1.54% 2.32% -1.36% 3.80% 3.38%
EBITDA Q/Q Growth		 6.95% 11.14% -8.31% 4.79% -12.85% 24.15% 1.10% -0.71% -4.51% 12.31% 2.71%
EBIT Q/Q Growth		 7.97% 14.28% -12.07% 1.94% -16.26% 31.93% 0.81% -1.66% -5.93% 16.30% 3.43%
NOPAT Q/Q Growth		 2.08% 13.75% -10.13% 4.11% -19.21% 33.25% -4.02% 0.94% -6.27% 16.99% 0.91%
Net Income Q/Q Growth		 12.00% 16.41% -15.79% 3.62% -22.56% 37.42% -2.59% 0.47% -6.55% 19.60% 0.42%
EPS Q/Q Growth		 11.11% 16.25% -15.59% 2.55% -21.74% 38.10% -2.30% 0.59% -5.85% 19.88% 1.04%
Operating Cash Flow Q/Q Growth		 -22.09% -14.69% 53.67% -15.93% -38.76% 52.98% 25.85% 2.95% -50.50% 92.86% 19.75%
Free Cash Flow Firm Q/Q Growth		 92.85% 2,022.04% -639.56% 32.26% -21.93% -9.60% 108.99% -91.98% 652.75% 309.84% 54.96%
Invested Capital Q/Q Growth		 -1.27% -0.52% 23.48% -2.39% 1.26% 1.75% 0.53% -0.96% 0.27% -0.68% -1.51%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 44.65% 45.44% 44.34% 42.54% 45.30% 45.32% 44.45% 43.05% 44.89% 46.36% 45.13%
EBITDA Margin		 25.57% 28.18% 26.13% 25.33% 23.39% 27.33% 27.21% 26.40% 25.56% 27.66% 27.48%
Operating Margin		 20.14% 22.63% 21.05% 19.16% 17.44% 21.71% 21.14% 20.42% 19.44% 21.71% 21.86%
EBIT Margin		 20.47% 23.20% 20.63% 19.46% 17.27% 21.44% 21.28% 20.45% 19.51% 21.86% 21.87%
Profit (Net Income) Margin		 15.15% 17.49% 14.90% 14.28% 11.72% 15.15% 14.53% 14.27% 13.52% 15.58% 15.13%
Tax Burden Percent		 78.51% 78.79% 77.01% 81.48% 76.63% 77.16% 74.90% 76.51% 76.37% 77.06% 74.73%
Interest Burden Percent		 94.26% 95.68% 93.75% 90.05% 88.55% 91.59% 91.18% 91.19% 90.75% 92.50% 92.60%
Effective Tax Rate		 21.49% 21.21% 22.99% 18.52% 23.37% 22.84% 25.10% 23.49% 23.63% 22.94% 25.27%
Return on Invested Capital (ROIC)		 11.99% 13.16% 10.89% 10.67% 9.16% 11.60% 10.14% 10.28% 9.90% 11.27% 11.28%
ROIC Less NNEP Spread (ROIC-NNEP)		 11.36% 12.84% 9.98% 9.64% 7.85% 10.20% 9.34% 9.38% 9.01% 10.46% 10.39%
Return on Net Nonoperating Assets (RNNOA)		 2.77% 3.17% 3.19% 2.93% 2.14% 2.64% 3.41% 3.22% 2.98% 3.43% 3.32%
Return on Equity (ROE)		 14.76% 16.33% 14.08% 13.60% 11.30% 14.24% 13.55% 13.50% 12.88% 14.70% 14.61%
Cash Return on Invested Capital (CROIC)		 9.74% 13.38% -12.51% -5.65% -8.54% -10.84% 8.78% 7.60% 8.94% 11.48% 13.88%
Operating Return on Assets (OROA)		 11.45% 12.74% 10.43% 10.09% 8.94% 11.21% 10.45% 10.34% 10.04% 11.35% 11.55%
Return on Assets (ROA)		 8.47% 9.60% 7.53% 7.40% 6.06% 7.92% 7.14% 7.22% 6.96% 8.09% 7.99%
Return on Common Equity (ROCE)		 14.76% 16.33% 14.08% 13.60% 11.30% 14.25% 13.55% 13.51% 12.88% 14.70% 14.61%
Return on Equity Simple (ROE_SIMPLE)		 15.95% 15.87% 12.82% 0.00% 12.25% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 127 144 129 135 109 145 139 140 132 154 155
NOPAT Margin		 15.81% 17.83% 16.21% 15.61% 13.36% 16.75% 15.84% 15.62% 14.85% 16.73% 16.33%
Net Nonoperating Expense Percent (NNEP)		 0.63% 0.32% 0.91% 1.03% 1.31% 1.40% 0.80% 0.91% 0.89% 0.81% 0.89%
Return On Investment Capital (ROIC_SIMPLE)		 - - - 2.34% 1.86% 2.47% 2.35% 2.40% 2.22% 2.63% 2.70%
Cost of Revenue to Revenue		 55.35% 54.56% 55.66% 57.46% 54.70% 54.68% 55.55% 56.95% 55.11% 53.64% 54.87%
SG&A Expenses to Revenue		 24.37% 22.65% 22.91% 22.93% 25.72% 23.53% 23.30% 22.37% 24.61% 24.34% 22.92%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 24.51% 22.81% 23.29% 23.39% 27.86% 23.61% 23.31% 22.63% 25.45% 24.65% 23.27%
Earnings before Interest and Taxes (EBIT)		 164 187 165 168 141 186 187 184 173 201 208
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 205 228 209 219 191 237 239 237 227 255 262
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.07 4.15 4.24 4.16 3.51 3.29 3.04 3.29 3.48 4.18 4.17
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 5.68 4.76 5.07 4.83 4.18 3.95 3.57 3.84 3.99 4.67 4.58
Price to Earnings (P/E)		 31.74 26.15 33.00 31.28 28.63 28.15 25.52 27.46 27.76 32.23 31.27
Dividend Yield		 1.06% 1.62% 1.24% 1.30% 1.53% 1.59% 1.73% 1.59% 1.50% 1.26% 1.27%
Earnings Yield		 3.15% 3.82% 3.03% 3.20% 3.49% 3.55% 3.92% 3.64% 3.60% 3.10% 3.20%
Enterprise Value to Invested Capital (EV/IC)		 4.40 3.67 3.32 3.30 2.87 2.71 2.51 2.73 2.88 3.39 3.43
Enterprise Value to Revenue (EV/Rev)		 5.90 4.95 5.52 5.24 4.59 4.34 3.95 4.20 4.36 5.01 4.89
Enterprise Value to EBITDA (EV/EBITDA)		 20.27 16.82 21.18 19.94 17.82 16.96 15.27 16.06 16.36 18.77 18.26
Enterprise Value to EBIT (EV/EBIT)		 24.32 20.26 26.40 25.06 22.80 22.00 19.84 20.82 21.08 24.13 23.36
Enterprise Value to NOPAT (EV/NOPAT)		 34.58 29.26 33.63 32.06 29.13 27.98 25.60 27.20 27.64 31.80 30.78
Enterprise Value to Operating Cash Flow (EV/OCF)		 26.25 21.98 25.31 25.65 24.40 22.46 20.99 21.33 22.67 25.09 23.78
Enterprise Value to Free Cash Flow (EV/FCFF)		 45.93 27.27 0.00 0.00 0.00 0.00 28.80 36.33 32.49 29.44 24.35
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.37 0.36 0.54 0.52 0.50 0.46 0.47 0.45 0.46 0.46 0.44
Long-Term Debt to Equity		 0.37 0.36 0.54 0.49 0.47 0.46 0.47 0.45 0.46 0.46 0.44
Financial Leverage		 0.24 0.25 0.32 0.30 0.27 0.26 0.36 0.34 0.33 0.33 0.32
Leverage Ratio		 1.69 1.68 1.75 1.72 1.69 1.67 1.78 1.75 1.72 1.72 1.73
Compound Leverage Factor		 1.59 1.60 1.64 1.55 1.49 1.53 1.62 1.59 1.56 1.59 1.60
Debt to Total Capital		 26.78% 26.21% 35.22% 34.07% 33.18% 31.54% 32.17% 31.14% 31.62% 31.69% 30.37%
Short-Term Debt to Total Capital		 0.01% 0.01% 0.01% 1.75% 1.72% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
Long-Term Debt to Total Capital		 26.77% 26.20% 35.21% 32.32% 31.46% 31.53% 32.16% 31.13% 31.61% 31.69% 30.37%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 -0.01% -0.01% -0.01% -0.01% -0.01% -0.02% -0.02% -0.02% -0.02% -0.02% -0.03%
Common Equity to Total Capital		 73.22% 73.79% 64.79% 65.95% 66.83% 68.48% 67.85% 68.88% 68.40% 68.33% 69.65%
Debt to EBITDA		 1.41 1.38 2.49 2.28 2.30 2.16 2.15 2.02 1.99 1.94 1.79
Net Debt to EBITDA		 0.75 0.64 1.73 1.56 1.59 1.50 1.48 1.37 1.37 1.29 1.17
Long-Term Debt to EBITDA		 1.41 1.38 2.49 2.16 2.18 2.16 2.15 2.01 1.99 1.94 1.79
Debt to NOPAT		 2.40 2.41 3.96 3.67 3.75 3.57 3.61 3.41 3.37 3.29 3.01
Net Debt to NOPAT		 1.28 1.11 2.75 2.51 2.60 2.47 2.48 2.33 2.31 2.19 1.98
Long-Term Debt to NOPAT		 2.40 2.41 3.96 3.48 3.56 3.57 3.60 3.41 3.37 3.29 3.01
Altman Z-Score		 6.67 5.90 4.65 4.83 4.47 4.42 4.13 4.43 4.68 5.20 5.30
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% -0.01% -0.01% -0.01% -0.02% -0.02% -0.02% -0.03% -0.03% -0.03%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.37 3.41 2.97 2.53 2.79 3.05 2.93 2.86 3.39 3.05 2.78
Quick Ratio		 2.29 2.36 1.96 1.73 1.84 1.97 1.94 1.91 2.25 2.01 1.81
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -9.54 183 -989 -670 -817 -896 81 6.46 49 199 309
Operating Cash Flow to CapEx		 783.00% 840.25% 1,498.54% 1,113.55% 739.16% 1,092.57% 1,375.00% 1,063.45% 585.88% 869.57% 950.40%
Free Cash Flow to Firm to Interest Expense		 -1.01 22.64 -96.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 16.66 16.49 19.93 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 14.53 14.53 18.60 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.56 0.55 0.51 0.52 0.52 0.52 0.49 0.51 0.51 0.52 0.53
Accounts Receivable Turnover		 7.30 7.24 7.05 7.32 7.13 7.41 7.02 7.00 6.82 7.00 6.98
Inventory Turnover		 3.91 3.91 3.81 4.29 4.09 4.06 3.87 4.22 4.06 3.93 3.94
Fixed Asset Turnover		 7.83 7.59 7.18 7.34 7.39 7.56 7.30 7.45 7.66 7.72 7.82
Accounts Payable Turnover		 9.00 9.83 9.21 9.66 9.27 9.87 9.09 9.08 9.06 9.06 9.04
Days Sales Outstanding (DSO)		 49.99 50.42 51.74 49.90 51.18 49.29 52.02 52.13 53.54 52.12 52.32
Days Inventory Outstanding (DIO)		 93.27 93.37 95.85 85.12 89.19 89.91 94.32 86.47 89.97 92.79 92.68
Days Payable Outstanding (DPO)		 40.58 37.14 39.65 37.78 39.39 36.98 40.15 40.19 40.28 40.31 40.39
Cash Conversion Cycle (CCC)		 102.68 106.66 107.94 97.23 100.97 102.22 106.20 98.41 103.23 104.60 104.61
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 4,326 4,303 5,313 5,186 5,252 5,344 5,372 5,320 5,335 5,298 5,218
Invested Capital Turnover		 0.76 0.74 0.67 0.68 0.69 0.69 0.64 0.66 0.67 0.67 0.69
Increase / (Decrease) in Invested Capital		 136 -39 1,119 805 926 1,041 59 134 83 -45 -154
Enterprise Value (EV)		 19,042 15,775 17,627 17,137 15,060 14,491 13,508 14,510 15,377 17,979 17,901
Market Capitalization		 18,335 15,178 16,185 15,798 13,715 13,213 12,201 13,270 14,093 16,743 16,753
Book Value per Share		 $47.80 $48.27 $50.45 $50.11 $51.55 $53.10 $53.28 $53.81 $54.47 $54.15 $54.48
Tangible Book Value per Share		 ($2.03) ($0.85) ($11.18) ($9.80) ($8.56) ($8.29) ($9.02) ($8.48) ($7.27) ($7.28) ($6.57)
Total Capital		 4,942 4,951 5,894 5,754 5,846 5,858 5,912 5,847 5,921 5,866 5,767
Total Debt		 1,324 1,298 2,076 1,960 1,940 1,848 1,902 1,821 1,872 1,859 1,752
Total Long-Term Debt		 1,323 1,297 2,075 1,860 1,839 1,847 1,902 1,820 1,872 1,859 1,751
Net Debt		 707 597 1,443 1,339 1,346 1,280 1,309 1,241 1,286 1,238 1,149
Capital Expenditures (CapEx)		 20 16 14 16 14 15 15 20 18 23 25
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 478 452 481 443 550 519 498 489 625 571 529
Debt-free Net Working Capital (DFNWC)		 1,095 1,153 1,114 1,064 1,144 1,088 1,092 1,069 1,211 1,192 1,131
Net Working Capital (NWC)		 1,094 1,152 1,113 963 1,043 1,087 1,091 1,068 1,211 1,192 1,131
Net Nonoperating Expense (NNE)		 5.26 2.76 10 11 13 14 11 12 12 11 11
Net Nonoperating Obligations (NNO)		 707 650 1,495 1,392 1,346 1,333 1,362 1,294 1,286 1,292 1,203
Total Depreciation and Amortization (D&A)		 41 40 44 51 50 51 52 54 54 53 53
Debt-free, Cash-free Net Working Capital to Revenue		 14.81% 14.17% 15.04% 13.55% 16.75% 15.54% 14.55% 14.13% 17.70% 15.92% 14.46%
Debt-free Net Working Capital to Revenue		 33.90% 36.13% 34.86% 32.54% 34.84% 32.55% 31.91% 30.90% 34.31% 33.25% 30.92%
Net Working Capital to Revenue		 33.88% 36.12% 34.84% 29.46% 31.78% 32.53% 31.89% 30.88% 34.30% 33.24% 30.91%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.60 $1.86 $1.57 $1.63 $1.26 $1.74 $1.70 $1.71 $1.61 $1.94 $1.95
Adjusted Weighted Average Basic Shares Outstanding		 75.70M 75.70M 75.70M 75.70M 75.70M 75.50M 75.10M 75.30M 74.30M 74M 73.70M
Adjusted Diluted Earnings per Share		 $1.60 $1.86 $1.57 $1.61 $1.26 $1.74 $1.70 $1.71 $1.61 $1.93 $1.95
Adjusted Weighted Average Diluted Shares Outstanding		 75.90M 75.90M 75.90M 75.90M 75.80M 75.50M 75.20M 75.30M 74.40M 74.20M 74M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 75.70M 75.70M 75.72M 75.78M 75.54M 75.29M 74.85M 74.35M 74.02M 73.72M 73.45M
Normalized Net Operating Profit after Tax (NOPAT)		 127 145 132 138 122 146 139 142 137 156 158
Normalized NOPAT Margin		 15.92% 17.96% 16.50% 15.98% 15.01% 16.82% 15.85% 15.83% 15.48% 16.97% 16.60%
Pre Tax Income Margin		 19.30% 22.20% 19.34% 17.52% 15.29% 19.63% 19.40% 18.65% 17.70% 20.22% 20.25%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 17.44 23.12 15.99 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 13.46 17.77 12.56 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 15.31 21.16 14.66 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 11.34 15.81 11.23 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 33.56% 34.06% 41.13% 40.69% 43.70% 44.92% 44.34% 44.06% 42.01% 41.09% 39.94%
Augmented Payout Ratio		 33.56% 38.06% 45.84% 40.69% 54.15% 66.26% 81.00% 95.42% 96.08% 99.09% 96.10%

Financials Breakdown Chart

Key Financial Trends

IDEX (NYSE:IEX) is showing improving operating momentum, although leverage, shareholder distributions and a sizable acquisition-related intangible asset base remain important considerations. The company’s latest results indicate stronger revenue, operating income and cash generation than a year earlier, while the balance sheet remains liquid but more leveraged than it was several years ago.

  • Revenue has accelerated: Q2 2026 revenue reached $920.6 million, up 6.4% from $865.4 million in Q2 2025 and 14.0% from Q2 2024. This follows a broader recovery from the $788.9 million reported in Q4 2023.
  • Operating profitability is improving: Q2 2026 operating income rose to $199.9 million from $172.4 million in Q1 2026 and $187.9 million in Q2 2025. The operating margin was approximately 21.7%, compared with 20.5% in Q2 2025 and 19.4% in Q1 2026.
  • Gross margin has expanded modestly: Q2 2026 gross profit was $426.8 million, representing a gross margin of about 46.4%, compared with roughly 45.3% in Q2 2025. This suggests improved revenue conversion despite higher sales and administrative costs.
  • Net income and earnings per share are trending higher: Q2 2026 net income attributable to common shareholders was $143.4 million, or $1.93 diluted EPS, compared with $131.6 million and $1.74 diluted EPS in Q2 2025. Diluted EPS has also increased from $1.44 in Q4 2023.
  • Operating cash flow rebounded sharply in the latest quarter: Cash flow from operations increased to $200.0 million in Q2 2026 from $161.7 million in Q2 2025. Capital spending was $23.0 million, producing approximately $177.0 million of quarterly free cash flow before other uses of cash.
  • Cash generation has generally remained strong: Operating cash flow was $209.5 million in Q4 2025 and $203.5 million in Q3 2025, well above the $167.3 million generated in Q4 2022. The company has consistently generated enough operating cash to fund capital expenditures and regular dividends.
  • Liquidity is comfortable: IDEX held $621.3 million of cash and equivalents at June 30, 2026. With $1.77 billion of current assets and $581.6 million of current liabilities, the current ratio was approximately 3.0.
  • Share repurchases are supporting per-share results: IDEX repurchased $77.1 million of common stock in Q2 2026 and $76.3 million in Q1. Weighted average basic shares declined to 74.0 million in Q2 2026 from 75.5 million in Q4 2024, helping boost EPS when earnings increase.
  • Working-capital performance is uneven: Operating assets and liabilities consumed $90.5 million of cash in Q1 2026, but the impact improved to a $2.9 million use in Q2. Investors should monitor receivables and inventories, which stood at $547.8 million and $520.3 million, respectively, at the latest quarter-end.
  • Restructuring costs have declined but have not disappeared: The Q2 2026 restructuring charge was $2.8 million, down from $7.4 million in Q1 2026 and $17.5 million in Q1 2025. Continued charges could limit the benefit of operating improvements, although the recent direction is favorable.
  • Debt is materially higher than several years ago: Long-term debt was $1.86 billion at June 30, 2026, compared with $1.30 billion at June 30, 2023. Q2 financing cash flow was negative $139.3 million despite a $105.0 million debt issuance, reflecting $118.1 million of repayments, $77.1 million of buybacks and $53.9 million of dividends.
  • Interest costs remain a drag on earnings: Net other expense was $13.8 million in Q2 2026, including $15.1 million of interest and investment expense. Cash interest paid was $19.3 million during the quarter, reducing the amount of operating cash available for reinvestment or debt reduction.
  • Shareholder returns are consuming substantial cash: IDEX paid $53.9 million in dividends and repurchased $77.1 million of stock in Q2 2026. Combined with debt repayments, these distributions exceeded quarterly free cash flow and contributed to reliance on new borrowing.
  • The balance sheet remains heavily weighted toward goodwill and intangibles: Goodwill of $3.38 billion and intangible assets of $1.16 billion represented approximately two-thirds of total assets at June 30, 2026. This reflects IDEX’s acquisition history and increases exposure to impairment risk if acquired businesses underperform.

Overall, the financial statements present a constructive operating picture: revenue has recovered, margins are improving and recent operating cash flow is strong. However, investors should balance that progress against higher debt, recurring interest expense and the company’s substantial goodwill and intangible asset balances. The key indicators to watch are whether revenue growth continues, whether working-capital cash usage remains controlled and whether IDEX can fund buybacks and dividends without allowing leverage to rise further.

11/01/26 06:58 PM ETAI Generated. May Contain Errors.

IDEX Financials - Frequently Asked Questions

According to the most recent income statement we have on file, IDEX's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

IDEX's net income appears to be on an upward trend, with a most recent value of $482.50 million in 2025, rising from $282.81 million in 2015. The previous period was $504.60 million in 2024. View IDEX's forecast to see where analysts expect IDEX to go next.

IDEX's total operating income in 2025 was $699.30 million, based on the following breakdown:
  • Total Gross Profit: $1.54 billion
  • Total Operating Expenses: $839.50 million

Over the last 10 years, IDEX's total revenue changed from $2.02 billion in 2015 to $3.46 billion in 2025, a change of 71.1%.

In the past 11 quarters, IDEX's cash and equivalents has ranged from $534.30 million in Q4 2023 to $700.70 million in Q2 2024, and is currently $602.10 million as of their latest financial filing in Q3 2026.

IDEX had total debt of $1.82 billion at the end of 2025, a 7.1% decrease from 2024, and a 116.8% increase since 2015.

Over the last 10 years, IDEX's book value per share changed from 18.86 in 2015 to 53.81 in 2025, a change of 185.3%.


Related Companies

Financial statements for NYSE:IEX last updated on 10/28/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
The 401k Email 70 Million Investors Might Delete
An email announcing a new 401k investment option is headed to roughly 70 million inboxes. Most recipients will...
Brownstone Research | Sponsoredtc pixel
My public warning after 55 years of watching the markets
Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...
Weiss Ratings | Sponsoredtc pixel
Don't lose access to this
Ian Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...
TradeWins | Sponsoredtc pixel
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
Does your nest egg have an expiration date?
A $250,000 nest egg growing at 5% a year and paying out $2,500 a month runs dry in just over a decade. Start w...
Investors Alley | Sponsoredtc pixel
Your free stock pick for today
Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he...
Behind the Markets | Sponsoredtc pixel
Cigar Lake Flooded Again Uranium Supply Shock Repeats
In 2006, a flooded mine at Cigar Lake sent uranium prices from the 50 range to 136 in eight months. This pa...
Digest Publishing | Sponsoredtc pixel
Last call for your free 0DTE report
The 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...
Profits Run | Sponsoredtc pixel